基于美国FDA不良事件报告系统数据库的免疫检查点抑制剂致糖尿病风险分析
彭净，吴明丽，任晓蕾，姜开杰，李兰芳，刘振，魏田田，孟路华，王美霞，班博
Analysis on the risk of diabetes mellitus related to immune checkpoint inhibitors based on the US FDA Adverse Event Reporting System
Peng Jing, Wu Mingli, Ren Xiaolei, Jiang Kaijie, Li Lanfang, Liu Zhen, Wei Tiantian, Meng Luhua, Wang Meixia, Ban Bo
药物不良反应杂志 . 2022, (3): 123 -129 .  DOI: 10.3760/cma.j.cn114015-20211022-01092